New BioMEMS Medical Device Platform "TopSpin" to

New BioMEMS Medical Device Platform "TopSpin" to Be Revealed by EPGL Medical and EP Global Communications, Inc., During "7 Days in April" Conference Call Series
David T. Markus Ph.D. Will Host Live Conference Call Series Starting April 24 through April 30, 2013.
IRVINE, Apr 22, 2013 (GLOBE NEWSWIRE via COMTEX) -- via PRWEB - EP Global Communications, Inc. (the Company), (Stock Ticker: EPGL) will reveal its new BioMEMS medical device platform, code named "TopSpin", during a series of conference calls hosted by David T. Markus Ph.D. this week. The calls will take place seven consecutive nights this week, starting Wednesday April 24 and concluding Tuesday April 30, 2013.

As one of the top BioMEMS engineers in the world, Dr. Markus along with others, will unveil the importance and value of EPGL's new BioMEMS device platform in today's medical marketplace. The new technology stands to spawn potentially dozens of new medical devices, giving doctors innovative new tools for diagnosis and treatment.

Shareholders and investors are encouraged to invite others who may be interested in learning more about EPGL and the new technology, to call 605-475-4000 and enter Code 475116#. Calls begin at 6:00 PM sharp and attendance is first come first served up to 100 people each night.

About David T. Markus, Ph.D. Vice President - BioMems Development

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery. Finally, Dr. Markus is fluent in English, Chinese-Madarin, Taiwanese-FuJian and Indonesian languages.

About EP Global Communications, Inc. / EPGL Medical

EP Global Communications, Inc. is a medical device manufacturer and marketing company with exclusive rights to a new FDA 510k cleared medical device called the Muscle Pain Detection Device. The MPDD is a revolutionary new diagnostic tool for the detection of muscular originated pain in the human body.

Safe Harbor Statement

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2013/4/prweb10655696.htm

  CONTACT: EP Global Communications, Inc. 
 
Brady Peterson 
 
investors@epglmed.com 
 
877-287-6175 
 
  

  (C) Copyright 2013 GlobeNewswire, Inc. All rights reserved. 
 
  

  KEYWORD:          IRVINE 
 
INDUSTRY KEYWORD: Business Services 
 
SUBJECT CODE:     Health